This week, companies adjust clinical trials amidst the coronavirus outbreak, GiveVision develops new AR-like glasses and scientists discover an unlikely link between tooth-enamel protein and dry AMD. Source: AAO
This study assessed the effect of combined blepharoplasty and Müller muscle-conjunctival resection (MMCR) surgery on dry eye syndrome. Source: AAO
Due to the COVID-19 pandemic, the Academy has issued a statement strongly recommending that all ophthalmologists cease providing any treatment other than urgent or emergent care immediately. Source: AAO
This single-center study investigates whether previous intravitreal anti-VEGF injections are a predictor for posterior capsular rupture (PCR) during phacoemulsification. Source: AAO
This retrospective, longitudinal study assessed the impact of OCT signal strength and artifact on retinal nerve fiber layer (RNFL) measurement reliability. Source: AAO
This week, a cat named Jinx undergoes life-changing eyelid surgery, Orbis’s flying eye hospital trains eye care teams on U.S. soil and positive phase 3 results from Kala’s dry eye drops. Source: AAO
In this study, investigators evaluated the economic value of anti-VEGF treatments for U.S. patients with wet AMD. Source: AAO
Researchers describe a new preventive method to mitigate posterior capsule opacification after cataract surgery in children. Source: AAO
The authors characterized the clinical features of patients with direct immunofluorescence (DIF)-negative mucous membrane pemphigoid (MMP). Source: AAO
This week, scientists inject a CRISPR-based treatment into a human eye, a novel contact lens shows promise for red-green color blindness and a biologic eye drop for ocular graft-versus-host disease snags orphan drug status. Source: AAO